Chitosan and Its Derivatives Functionalized Drug Delivery Systems for Biomedical Application
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 1117
Special Issue Editors
Interests: pharmaceutics; nanomedicine; biological barrier regulation; drug controlled release; drug target and therapy; nanoparticles
Special Issue Information
Dear Colleagues,
Chitosan, as the only naturally occurring polycationic polysaccharide, has been widely implicated in the design of drug delivery systems for various biomedical applications due to its considerable biocompatibility and biodegradability. Furthermore, chitosan derivatives obtained via chemical modification of functional groups always display better stability and higher water solubility than chitosan, which also hold promising potential in broadening the application than its predecessors, such as drug delivery, antibacterial activity or anticancer capabilities. Glycated Chitosan and N-dihydro-galacto-chitosan, respectively, are combined with thermal ablation or laser strategy for tumor therapy in clinical trials, where chitosan derivatives act as adjuvants. Chitosan and its derivatives functionalized nanoparticles possess large numbers of lone-pair electrons, making it possible for gene delivery or drug loading via electrostatic adsorption, which was also utilized to fabricate polyplexes via ionically crosslinking when chitosan functions as a framework. The high water solubility of the derivatives of chitosan is why there have been extensive attempts to design polymeric nanoparticles for drug delivery.
This Special Issue aims to invite submissions concerning new trends in the biomedical application of chitosan and its derivatives. Contributions may focus on chitosan and its derivatives functionalized drug delivery systems, such as hydrogels, micelles or muti-component nanoscale systems. Potential interests may include, but are not limited to, anti-cancer activity, tissue regeneration ability, oral delivery and anti-microbial capabilities. In this Special Issue, original research articles and reviews are welcome.
We look forward to receiving your contributions.
Prof. Dr. Fuqiang Hu
Prof. Dr. Hong Yuan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chitosan and its derivatives
- anti-cancer therapy
- oral delivery
- tissue regeneration
- adjuvants
